Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id,Id,entityId
PublicationView,CA256481,10.3892/ijo.2023.5565,Int J Oncol,37654190,https://pubmed.ncbi.nlm.nih.gov/37654190,"CHCHD2 mediates glioblastoma cell proliferation, mitochondrial metabolism, hypoxia‚Äëinduced invasion and therapeutic resistance",2023,"Mitochondria, Glioblastoma, Epidermal Growth Factor Receptor Variant Iii, Coiled‚Äëcoil‚Äëhelix‚Äëcoiled‚Äë Coil‚Äëhelix Domain‚Äëcontaining Protein 2","Jan C Lumibao, Payton L Haak, Vladimir L Kolossov, Jee-Wei Emily Chen, Jeremy Stutchman, Alejandra Ruiz, Mayandi Sivaguru, Jann N Sarkaria, Brendan A C Harley, Andrew J Steelman, H Rex Gaskins","Glioblastoma (GBM) is the most common and malignant primary brain tumor affecting adults and remains incurable. The mitochondrial coiled‚Äëcoil‚Äëhelix‚Äëcoiled‚Äëcoil‚Äëhelix domain‚Äëcontaining protein 2 (CHCHD2) has been demonstrated to mediate mitochondrial respiration, nuclear gene expression and cell migration; however, evidence of this in GBM is lacking. In the present study, it was hypothe(Read more on Pubmed)","Cell Culture, Cell Proliferation Assay, Cytotoxicity Assay, Hydrogels, Western Blotting",Glioblastoma,Brain,Not Applicable,Open Access,37654190,dede4b69-566a-4e56-b129-9b9cf8e2c0dd,syn52566242
